Skip to main content
. 2020 May 27;33:100582. doi: 10.1016/j.gore.2020.100582

Table 3.

Performance of BRCA2 immunohistochemistry (IHC) and BRCA mutation status.

BRCA1 mutation (N = 9) BRCA2 mutation (N = 6) No BRCA1/2 mutation (N = 90)
BRCA2 IHC loss (N = 24) 6 (66.7%) 3 (50%) 15 (16.7%)
BRCA2 IHC intact (N = 81) 3 (33.3%) 3 (50%) 75 (83.3%)